CRSP insider trading
CRISPR Therapeutics AG · end-of-day data as of Nov 13, 2026
CRISPR Therapeutics
$42.24-0.9%
PT $72.45 +71.5%▲ 4
- PT$72.45 +71.5%
- ConsensusBuy · 23
- Bollingerbelow lower
- Sector▲ +15.9%
Neutral
- Earnings in90d
- RSI32
- Support-7.6%
- Resistance+0.3%
- Off 52w high-33.4%
- Volume1.2x
- News0.00
- Trendsideways
- 52w range$42–$63
- ATR+6.3%
- Off ATH-80.8%
▼ 4
- FCF yield-9.3%
- Insiders-$4.88M
- MAs0 of 4
- MACD-0.81
Updates with the 15-min delayed price. Not a forecast or investment advice.
![]()
Last 90 days
- Insiders-$4.88M
Transactions
Open-market buys $0 · sells $17.94M over the last 365 days (0 buys, 24 sells).
| Nov 4, 2026 | Sakhamuri Sivakesava | Other | 130,000 | $51.78 | $4.66M |
| Nov 2, 2026 | Sakhamuri Sivakesava | Other | 0 | — | — |
| Oct 26, 2026 | KASINGER JAMES R. | Other | 27,000 | $49.01 | $882K |
| Oct 26, 2026 | Kulkarni Samarth | Other | 86,250 | $49.01 | $2.82M |
| Oct 26, 2026 | Patel Naimish | Other | 36,000 | $49.01 | $1.18M |
| Oct 26, 2026 | Silver Andrew Jacob | Other | 27,000 | $49.01 | $882K |
| Oct 19, 2026 | Kulkarni Samarth | Sell | 47,837 | $49.78 | $2.38M |
| Oct 19, 2026 | Silver Andrew Jacob | Other | 25,000 | — | $0 |
| Oct 16, 2026 | Kulkarni Samarth | Other | 200,000 | — | — |
| Oct 14, 2026 | George Simeon | Sell | 14,514 | $49.63 | $720K |
| Oct 14, 2026 | George Simeon | Other | 60,000 | $14.00 | $840K |
| Oct 14, 2026 | KASINGER JAMES R. | Sell | 1,040 | $49.26 | $51.23K |
| Oct 14, 2026 | Kulkarni Samarth | Sell | 4,098 | $49.26 | $202K |
| Oct 13, 2026 | KASINGER JAMES R. | Other | 4,226 | — | — |
| Oct 13, 2026 | Kulkarni Samarth | Other | 16,666 | — | — |
| Oct 6, 2026 | KASINGER JAMES R. | Sell | 1,990 | $60.04 | $119K |
| Oct 6, 2026 | KASINGER JAMES R. | Other | 3,980 | $13.62 | $54.21K |
| Sep 22, 2026 | KASINGER JAMES R. | Sell | 10,400 | $60.24 | $626K |
| Sep 22, 2026 | KASINGER JAMES R. | Other | 20,800 | $13.62 | $283K |
| Sep 17, 2026 | Behbahani Ali | Other | 60,000 | $14.00 | $840K |
Source: SEC Form 4 filings. "Other" covers awards, option exercises and gifts.